These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 478089)

  • 1. Retinal fluorescein angiography and hemoglobin A1C in borderline diabetes.
    Nielsen NV; Sorensen PN; Ditzel J
    Diabete Metab; 1979 Jun; 5(2):97-101. PubMed ID: 478089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein angiography in persons with slightly abnormal glucose tolerances.
    Nielsen NV
    Acta Endocrinol Suppl (Copenh); 1980; 238():77-84. PubMed ID: 6933818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein angiography in borderline diabetics.
    Viberti GC; Jarrett RJ; Watson DM; Clements C; Keen H
    Diabete Metab; 1979 Jun; 5(2):93-6. PubMed ID: 478088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1 in the diagnosis of chemical diabetes mellitus.
    Clipson KL; Kansal PC; Poon MC; Boshell BR
    Horm Metab Res; 1981 Mar; 13(3):129-31. PubMed ID: 7239422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fasting glycosylated hemoglobin A1c and behavior of blood sugar and blood insulin after oral glucose tolerance test in subjects with a family history of diabetes].
    Ferrero E; Casale G; Ricci C; Ravecca D
    Minerva Med; 1981 May; 72(20):1289-94. PubMed ID: 7017475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.
    Bursell SE; Clermont AC; Kinsley BT; Simonson DC; Aiello LM; Wolpert HA
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):886-97. PubMed ID: 8603873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean retinal circulation time as determined by fluorescein angiography in normal, prediabetic, and chemical-diabetic subjects.
    Soeldner JS; Christacopoulos PS; Gleason RE
    Diabetes; 1976; 25(2 SUPPL):903-8. PubMed ID: 971794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy?
    Holmes-Walker DJ; Mitchell P; Boyages SC
    Diabet Med; 1998 Nov; 15(11):946-52. PubMed ID: 9827849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hemoglobin A1c and insulin C-peptide in anomalies of carbohydrate metabolism.
    Perier C; Hivert M; Frey J; Rousset H; Janin J
    Biomedicine; 1980 Nov; 33(7):232-6. PubMed ID: 7013838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin A1c as an indicator of long term blood glucose levels in diabetics with special reference to diabetic pregnancy.
    Kjaergaard JJ; Hansen P; Madsen H; Ditzel J
    Acta Endocrinol Suppl (Copenh); 1980; 238():25-9. PubMed ID: 7001836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected hypoglycaemia, haemoglobin A1 and diabetic control.
    Dornan TL; Peckar CO; Mayon-White VA; Knight AH; Moore RA; Hockaday TD; Bron AJ; Turner RC
    Q J Med; 1981; 50(197):31-8. PubMed ID: 7022541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru--the 1982 survey.
    Zimmet P; King H; Taylor R; Raper LR; Balkau B; Borger J; Heriot W; Thoma K
    Diabetes Res; 1984 May; 1(1):13-8. PubMed ID: 6529880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic control in 107 maturity onset diabetic out patients (author's transl)].
    Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J; Tchobroutsky G
    Nouv Presse Med; 1980 Feb; 9(9):585-9. PubMed ID: 6987621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting plasma beta-thromboglobulin in diabetes mellitus.
    Rasi V; Ikkala E; Hekali R; Myllylä G
    Med Biol; 1980 Oct; 58(5):269-72. PubMed ID: 6163046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin AIc and red cell oxygen release capacity in relation to early retinal changes in newly discovered overt and chemical diabetics.
    Ditzel J; Nielsen NV; Kjaergaard JJ
    Metabolism; 1979 Apr; 28(4 Suppl 1):440-7. PubMed ID: 400564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical topics: hemoglobin A1c--a new index for controlling blood sugar].
    Iizuka T
    Kango; 1980 Jan; 32(1):108-9. PubMed ID: 6898724
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.